| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0738-081X(99)00136-4 |
| P698 | PubMed publication ID | 11024308 |
| P2093 | author name string | Johnson RA | |
| P2860 | cites work | Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men: evidence of a new acquired cellular immunodeficiency | Q34055177 |
| Disseminated Penicillium marneffei infection in southeast Asia | Q34059537 | ||
| Infection due to Penicillium marneffei, an emerging pathogen: review of 155 reported cases | Q34398225 | ||
| Aspergillus species colonization and invasive disease in patients with AIDS | Q36043483 | ||
| Fluconazole-resistant candidosis in an HIV cohort. | Q38888651 | ||
| Primary prevention of cryptococcal meningitis by fluconazole in HIV-infected patients | Q39381633 | ||
| Antifungal agents: an overview. Part II. | Q40449449 | ||
| Terbinafine for the treatment of pedal onychomycosis. A foot closer to the promised land of cured nails? | Q40458491 | ||
| Cutaneous disseminated histoplasmosis in AIDS patients in south Florida | Q40647165 | ||
| Fungemia in children infected with the human immunodeficiency virus: new epidemiologic patterns, emerging pathogens, and improved outcome with antifungal therapy | Q40686473 | ||
| Opportunistic candidal infections in patients infected with human immunodeficiency virus: prevention issues and priorities | Q40938533 | ||
| Cutaneous Cryptococcus infection and AIDS. Report of 12 cases and review of the literature | Q40983237 | ||
| Is vulvovaginal candidiasis an AIDS-related illness? | Q41045009 | ||
| Fungal infections in HIV-infected patients | Q41595868 | ||
| Itraconazole pulse therapy for onychomycosis and dermatomycoses: an overview | Q41674262 | ||
| Terbinafine: an update | Q41674270 | ||
| Weekly fluconazole for the prevention of mucosal candidiasis in women with HIV infection. A randomized, double-blind, placebo-controlled trial. Terry Beirn Community Programs for Clinical Research on AIDS. | Q42655153 | ||
| Unusual Microsporum canis infections in adult HIV patients | Q43665084 | ||
| Prevalence of onychomycosis in patients attending a dermatology clinic in northeastern Ohio for other conditions | Q43836501 | ||
| Cutaneous disease and drug reactions in HIV infection | Q44111761 | ||
| Nonscalp hair infection caused by Microsporum canis in patient with acquired immunodeficiency syndrome | Q44376828 | ||
| Superficial phaeohyphomycosis of the scrotum in a patient with the acquired immunodeficiency syndrome | Q44820771 | ||
| Once-weekly oral doses of fluconazole 150 mg in the treatment of tinea pedis | Q44897396 | ||
| Hierarchical pattern of mucosal candida infections in HIV-seropositive women | Q44941577 | ||
| Risk factors for fluconazole-resistant candidiasis in human immunodeficiency virus-infected patients | Q45254690 | ||
| Nail changes in patients infected with human immunodeficiency virus. A prospective controlled study | Q45753022 | ||
| Prospective study of histoplasmosis in patients infected with human immunodeficiency virus: incidence, risk factors, and pathophysiology | Q45762381 | ||
| Case-control study of risk factors for Penicillium marneffei infection in human immunodeficiency virus-infected patients in northern Thailand | Q45762390 | ||
| Patterns of fluconazole susceptibility in isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasis due to Candida albicans | Q45763707 | ||
| Estimation of the prevalence of cryptococcal infection among patients infected with the human immunodeficiency virus in New York City | Q45783621 | ||
| A randomized trial comparing fluconazole with clotrimazole troches for the prevention of fungal infections in patients with advanced human immunodeficiency virus infection. NIAID AIDS Clinical Trials Group | Q45784081 | ||
| Cutaneous cladosporiosis as a complication of skin testing in a man positive for human immunodeficiency virus | Q45849551 | ||
| Generalized Chronic Dermatophytosis in Patients With Human Immunodeficiency Virus Type I Infection and CD4 Depletion | Q45860716 | ||
| Esophageal candidiasis associated with acute infection due to human immunodeficiency virus | Q45867147 | ||
| Time from HIV seroconversion to oral candidiasis or hairy leukoplakia among homosexual and bisexual men enrolled in three prospective cohorts. | Q46081764 | ||
| Primary cutaneous aspergillosis near central venous catheters in patients with the acquired immunodeficiency syndrome | Q46163027 | ||
| Disseminated cutaneous fungal infection and AIDS. | Q46307813 | ||
| Disseminated African histoplasmosis in a Congolese patient with AIDS. | Q46368246 | ||
| One-week therapy with oral terbinafine in cases of tinea cruris/corporis | Q46731129 | ||
| Invasive aspergillosis in patients with AIDS. | Q48565518 | ||
| Use of terbinafine in HIV-positive subjects: pilot studies in onychomycosis and oral candidiasis. | Q53986887 | ||
| Onychomycosis and AIDS. Clinical and laboratory findings in 62 patients | Q68420918 | ||
| HIV infection in children | Q68521680 | ||
| Seborrheic-like dermatitis of acquired immunodeficiency syndrome. A clinicopathologic study | Q69989152 | ||
| Clinical pearl: proximal white subungual onychomycosis in AIDS | Q70502533 | ||
| Scutular favus-like tinea cruris et pedis in a patient with AIDS | Q71120150 | ||
| Intermittent fluconazole dosing in patients with onychomycosis: results of a pilot study | Q71260062 | ||
| Prophylaxis with nystatin pastilles for HIV-associated oral candidiasis | Q71396955 | ||
| Epidemiology of cryptococcosis in France: a 9-year survey (1985-1993). French Cryptococcosis Study Group | Q71554754 | ||
| Bonsai tree: Risk factor for disseminated sporotrichosis | Q71826583 | ||
| Infection due to fluconazole-resistant Candida in patients with AIDS: prevalence and microbiology | Q71972430 | ||
| Cutaneous manifestations of disseminated cryptococcosis | Q72168357 | ||
| Seborrheic Dermatitis and Butterfly Rash in AIDS | Q72818525 | ||
| A randomized, double-blind comparison of itraconazole oral solution and fluconazole tablets in the treatment of esophageal candidiasis | Q73476103 | ||
| Disseminated dermatophytosis caused by Microsporum gypseum in two patients with the acquired immunodeficiency syndrome | Q73703570 | ||
| Toenail onychomycosis in patients with acquired immune deficiency syndrome: treatment with terbinafine | Q73924484 | ||
| The prevalence of skin disease in HIV infection and its relationship to the degree of immunosuppression | Q73924500 | ||
| Randomized trial of itraconazole oral solution for oropharyngeal candidiasis in HIV/AIDS patients | Q74404194 | ||
| P433 | issue | 4 | |
| P304 | page(s) | 411-422 | |
| P577 | publication date | 2000-07-01 | |
| P1433 | published in | Clinics in Dermatology | Q5133863 |
| P1476 | title | HIV disease: mucocutaneous fungal infections in HIV disease | |
| P478 | volume | 18 |
| Q40427763 | Disseminated histoplasmosis in acquired immunodeficiency syndrome patients in Uberaba, MG, Brazil |
| Q46789764 | Proximal subungual onychomycosis caused by Fusarium falciforme successfully cured with posaconazole. |
| Q42713791 | Tinea incognito Caused by Microsporum gypseum in a Patient with Advanced HIV Infection: A Case Report |
Search more.